How does coumarin work in insulin resistance for diabetes mellitus type 2? (A literature review)
DOI: https://doi.org/10.33024/minh.v8i4.722
Coumarin Diabetes Mellitus Type 2 Insulin Resistance
Abstract
Background: Coumarin is a natural compound found in various plants, including Cinnamomum cassia and Cinnamomum zeylanicum, and has been widely studied for its potential role in metabolic regulation, particularly in diabetes mellitus type 2. While coumarin has shown potential benefits in improving glycemic control, concerns regarding its hepatotoxic and carcinogenic effects remain.
Purpose: To review the literature on how coumarin works in insulin resistance in people with type 2 diabetes.
Method: A literature review was conducted using the ClinicalKey, Science Direct, and Google Scholar databases. Boolean operators (AND, OR, NOT) were used to refine the search. Inclusion criteria included research articles published between 2015 and 2024 in accredited national or internationally reputable journals, with a JBI critical appraisal tools score above 65%. The PRISMA diagram was used for article selection, resulting in five eligible articles for analysis.
Results: The findings indicate that coumarin, predominantly found in cinnamon, has glucose-lowering effects in diabetes mellitus type 2 patients by reducing blood glucose levels, controlling glucose spikes, and lowering HbA1c. Additionally, coumarin derivatives in Opuntia ficus-indica and Smallanthus sonchifolius (yacon) may contribute to metabolic homeostasis through antioxidant activity. However, coumarin also poses hepatotoxic and carcinogenic risks at high doses.
Conclusion: While coumarin-containing compounds show promise in improving glycemic control. Further research is needed to determine safe and effective therapeutic doses for clinical application.
Downloads
References
Al Dhaheri, A. S., Alkhatib, D. H., Feehan, J., Cheikh Ismail, L., Apostolopoulos, V., & Stojanovska, L. (2024). The effect of therapeutic doses of culinary spices in metabolic syndrome: A randomized controlled trial. Nutrients, 16(11), 1685.
Anywar, G., & Muhumuza, E. (2024). Bioactivity and toxicity of coumarins from African medicinal plants. Frontiers in Pharmacology, 14, 1231006.
Baroni, S., da Rocha, B. A., de Melo, J. O., Comar, J. F., Caparroz-Assef, S. M., & Bersani-Amado, C. A. (2016). Hydroethanolic extract of Smallanthus sonchifolius leaves improves hyperglycemia of streptozotocin induced neonatal diabetic rats. Asian Pacific journal of tropical medicine, 9(5), 432-436.
De Oliveira, R. B., De Paula, D. A. C., Rocha, B. A., Franco, J. J., Gobbo-Neto, L., Uyemura, S. A., & Da Costa, F. B. (2011). Renal toxicity caused by oral use of medicinal plants: the yacon example. Journal of ethnopharmacology, 133(2), 434-441.
Di Majo, D., Ricciardi, N., Di Liberto, V., Allegra, M., Frinchi, M., Urone, G., & Gambino, G. (2024). The remarkable impact of Opuntia Ficus Indica fruit administration on metabolic syndrome: Correlations between cognitive functions, oxidative stress and lipid dysmetabolism in the high-fat, diet-fed rat model. Biomedicine & Pharmacotherapy, 177, 117028.
Flores-Morales, V., Villasana-Ruíz, A. P., Garza-Veloz, I., González-Delgado, S., & Martinez-Fierro, M. L. (2023). Therapeutic effects of coumarins with different substitution patterns. Molecules, 28(5), 2413.
Ganjeh, M. S., Mazlomifar, A., Shahvelayti, A. S., & Moghaddam, S. K. (2024). Coumarin linked to 2-phenylbenzimidazole derivatives as potent α-glucosidase inhibitors. Scientific Reports, 14(1), 7408.
Ghosh, S., Ghosh, A., Rajanan, A., Suresh, A. J., Raut, P. S., Kundu, S., & Sahu, B. D. (2022). Natural coumarins: Preclinical evidence-based potential candidates to alleviate diabetic nephropathy. Phytomedicine Plus, 2(4), 100379.
Husain, A. A., Husain, A. S., Gawhale, N. D., Khan, S. L., Murlidhar, D. V., Siddiqui, F. A., & Kazi, A. A. (2022). An Overview of Natural and Synthetic Coumarin Derivatives as Potential Antidiabetic Agents. Journal of Pharmaceutical Negative Results, 13.
Hussain, M. I., Syed, Q. A., Khattak, M. N. K., Hafez, B., Reigosa, M. J., & El-Keblawy, A. (2019). Natural product coumarins: biological and pharmacological perspectives. Biologia, 74, 863-888.
Khouzani, M. A., Mogharabi, M., Faramarzi, M. A., Mojtabavi, S., Azizian, H., Mahdavi, M., & Hashemi, S. M. (2023). Development of coumarin tagged 1, 2, 3-triazole derivatives targeting α-glucosidase inhibition: Synthetic modification, biological evaluation, kinetic and in silico studies. Journal of Molecular Structure, 1282, 135194.
Lončar, M., Jakovljević, M., Šubarić, D., Pavlić, M., Buzjak Služek, V., Cindrić, I., & Molnar, M. (2020). Coumarins in food and methods of their determination. Foods, 9(5), 645.
Pan, Y., Liu, T., Wang, X., & Sun, J. (2022). Research progress of coumarins and their derivatives in the treatment of diabetes. Journal of Enzyme Inhibition and Medicinal Chemistry, 37(1), 616-628.
Pitaro, M., Croce, N., Gallo, V., Arienzo, A., Salvatore, G., & Antonini, G. (2022). Coumarin-induced hepatotoxicity: A narrative review. Molecules, 27(24), 9063.
Prahayati, S., & Rusdi, B. (2023). Uji In Silico Aktivitas Senyawa Kumarin Turunannya Terhadap Enzim Alfa Glukosidase Antidiabetes. Jurnal Riset Farmasi, 9-16.
Ranđelović, S., & Bipat, R. (2021). A review of coumarins and coumarin-related compounds for their potential antidiabetic effect. Clinical Medicine Insights: Endocrinology and Diabetes, 14, 11795514211042023.
Sohrabi, M., Binaeizadeh, M. R., Iraji, A., Larijani, B., Saeedi, M., & Mahdavi, M. (2022). A review on α-glucosidase inhibitory activity of first row transition metal complexes: a futuristic strategy for treatment of type 2 diabetes. RSC advances, 12(19), 12011-12052.
Wariyapperuma, W. A. N. M., Jayawardena, B., Thammitiyagodage, M. G., Karunakaran, R., & Kumara, W. G. S. S. (2021). Hypoglycemic and anti-lipidemic properties of Cinnamomum zeylanicum (” Sri Wijaya” accession) water-soluble nutraceutical in streptozotocin-induced diabetic and healthy wistar rats. Pharmacognosy Magazine, 17(06).
Yamada, T., Katsutani, N., Maruyama, T., Kawamura, T., Yamazaki, H., Murayama, N., & Hirose, A. (2022). Combined risk assessment of food-derived coumarin with in Silico approaches. Food Safety, 10(3), 73-82.
Zelicha, H., Yang, J., Henning, S. M., Huang, J., Lee, R. P., Thames, G., & Li, Z. (2024). Effect of cinnamon spice on continuously monitored glycemic response in adults with prediabetes: a 4-week randomized controlled crossover trial. The American Journal of Clinical Nutrition, 119(3), 649-657.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Arwani Arwani, Afifah Salsabila
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
